Week 3 Immunization Case Study Assignment

Week 3 Immunization Case Study Assignment

Identify vaccines available in the US market for vaccine-preventable disease and describe their features. Identify contraindications and precautions for the use of vaccines available. Use recommendations from the Advisory Committee on Immunization Practice (ACIP) to identify target groups for receipt of each vaccine.

The Immunization assignment is worth 100 points and will be graded on the quality of the content, use of citations, use of Standard English grammar, sentence structure, and overall organization based on the required components as summarized in the directions and grading criteria/rubric. Submit the paper as a Microsoft Word Document, which is the required format at Chamberlain University. Follow the directions below and the grading criteria located in the rubric closely. Any questions about this paper may be posted under the Q & A Forum or emailed to your faculty. The length of the paper should be 2-3 pages, excluding title page and reference page(s). The title and reference pages should be in APA format. Vaccination schedules should be obtained directly from the Centers for Disease Control and Prevention: Resources for Healthcare Providers website and reflect the most current recommendations from the Advisory Committee on Immunization Practices (ACIP). Additional scholarly resources may be used and all sources must be cited appropriately.

Following the directions above, answer each of the following case scenario questions:

Case # 1

You are rotating in the newborn nursery. Your next admission is a term newborn born at 3.5 kg, and all maternal labs are negative. The infant's exam is normal.

  1. What vaccine(s) should she receive and why?
  2. What would you do if the mother tested positive for Hepatitis B?
  3. What would you do if the mother's Hepatitis B status was unknown?

Case # 2

Your first patient in primary care clinic is a healthy 2-month-old. She received Hep B #1 in the nursery. She is a term infant and parents have no concerns. Her exam is normal and there are no contraindications to giving her vaccines.

  1. Which vaccines should the child receive at this visit?
  2. When should she return and which ones would you administer at the next visit?
  3. Which vaccination combinations can be used to minimize the number of needle injections, if available?

Case # 3

A healthy 5-year-old comes in with her mother for a well-child check in November. Her routine vaccines are up to date through 2 years old, but she has never received a vaccine for influenza. Her exam is normal.

  1. Which vaccines do you recommend at this visit?
  2. What anticipatory guidance should be given for a child receiving a flu vaccine at this age?
  3. Are there any contraindications for the vaccines that you recommended today?

Case # 4

An 11-year-old girl presents for a routine well-child check. Her immunizations are up to date. Her exam is normal and there are no contraindications to giving her vaccines.

  1. Which vaccine(s) do you recommend at this visit?
  2. The mother states she only wants her daughter to have "the one required for school this year but not the others." How should the Nurse Practitioner counsel the mother and the patient?
  3. The mother is agreeable to proceed with vaccine administration today. Are additional doses needed? If yes, state which ones and when.

Paper For Above instruction

Immunizations are a cornerstone of public health efforts aimed at preventing infectious diseases. The landscape of vaccines available in the United States is continuously evolving, guided by rigorous scientific research and recommendations from authoritative bodies such as the Advisory Committee on Immunization Practices (ACIP). This paper explores vaccine options for different age groups, their features, contraindications, precautions, and target populations, illustrating their application in various clinical scenarios.

The US market offers a broad array of vaccines designed to prevent numerous infectious diseases. Key vaccines include the Measles-Mumps-Rubella (MMR), Varicella, Influenza, Diphtheria, Tetanus, Pertussis (DTaP or Tdap), Polio (IPV), Hepatitis B, and Pneumococcal vaccines. These vaccines differ in their composition, dosing schedules, duration of immunity, and specific indications. For example, the MMR vaccine is a live-attenuated vaccine administered in two doses, primarily targeting children and susceptible populations (CDC, 2023). The pneumococcal conjugate vaccine (PCV13) protects against Streptococcus pneumoniae infections and is recommended for infants and certain high-risk groups (WHO, 2023).

Contraindications and precautions are critical considerations in immunization practices. Live vaccines, such as MMR and Varicella, are typically contraindicated in immunocompromised individuals and pregnant women due to the risk of vaccine-induced illness (CDC, 2023). Precautions include managing transient febrile reactions or allergic responses. Absolute contraindications, such as severe allergic reactions to vaccine components, must be carefully assessed before administration (WHO, 2023). Understanding these factors ensures vaccine safety and efficacy.

ACIP provides updated guidelines for target populations for each vaccine. For infants, the routine schedule includes the Hepatitis B vaccine at birth, DTaP, IPV, Hib, PCV13, and Rota vaccines starting at 2 months (CDC, 2023). School-aged children and adolescents are recommended to receive Tdap, HPV, and Meningococcal vaccines. High-risk groups, including immunocompromised patients and travelers, have specific vaccination requirements outlined in ACIP guidelines (CDC, 2023).

Case Scenario Applications

Case #1: Newborn with Negative Maternal Labs

A term neonate with negative maternal labs and normal exam warrants the administration of the Hepatitis B vaccine within 24 hours of birth to prevent vertical transmission (CDC, 2023). If the mother tests positive for Hepatitis B, administration of the Hepatitis B vaccine and Hepatitis B Immunoglobulin (HBIG) within 12 hours is essential to reduce vertical transmission risk (WHO, 2023). When maternal status is unknown, it is prudent to administer the vaccine and HBIG as a precaution until maternal serology results are available, aligning with CDC recommendations for exposure prophylaxis (CDC, 2023).

Case #2: 2-Month-Old Infant

At 2 months, infants should receive the second doses of DTaP, IPV, Hib, PCV13, and the third dose of Hepatitis B if not already given. Additionally, the Rotavirus vaccine is administered starting at this age (CDC, 2023). Use of combination vaccines, such as Tetramune or Pediarix, minimizes needle sticks and improves compliance. These combinations include DTaP, IPV, Hepatitis B, and others, streamlining immunization schedules (CDC, 2023).

Case #3: 5-Year-Old with No Flu Vaccine

For a 5-year-old, the annual influenza vaccine is recommended, along with reviewing the status of other vaccines. The 5-year-old should receive the DTaP booster, the inactivated Polio vaccine, MMR, Varicella if not previously administered, and Meningococcal conjugate vaccine. The flu vaccine at this age should be administered annually to protect against circulating strains (CDC, 2023). Mild side effects such as soreness or low-grade fever are common but do not contraindicate vaccination.

Case #4: 11-Year-Old for School Entry

At 11 years, the Tdap booster is necessary to maintain pertussis immunity. The Meningococcal conjugate vaccine is also recommended for adolescents, with a booster dose typically given at age 16. HPV vaccination offers protection against human papillomavirus-related cancers and is recommended for both sexes starting at age 11 or 12. If the mother prefers only the minimum required vaccines, counseling on the benefits of comprehensive immunization and herd immunity is essential. Additional doses, such as the Meningococcal booster, are needed to ensure continued protection (CDC, 2023).

Conclusion

Immunization practices are grounded in evidence-based guidelines aimed at preventing disease and reducing morbidity and mortality. Tailoring vaccination strategies to individual patient scenarios requires understanding available vaccines, their features, contraindications, and the latest ACIP recommendations. Through careful assessment and patient education, healthcare providers can optimize immunization outcomes and support public health efforts.

References

  • Centers for Disease Control and Prevention. (2023). Immunization schedules. https://www.cdc.gov/vaccines/schedules/index.html
  • World Health Organization. (2023). Vaccines and immunization. https://www.who.int/immunization/en/
  • Heininger, U., & Lavergne, A. (2022). Immunization safety in children. Journal of Pediatric Infectious Diseases, 4(2), 89-97.
  • Walker, T. Y., et al. (2019). Vaccine-preventable diseases: Review of vaccination guidelines. Vaccine Journal, 37(12), 1650-1656.
  • Gupta, R., & Schuster, M. (2021). Pediatric immunizations: Principles and practice. Pediatric Annals, 50(3), e118-e123.
  • Millis, R. M., & McIntyre, P. B. (2020). Strategies for vaccine administration compliance. International Journal of Infectious Diseases, 96, 134-140.
  • American Academy of Pediatrics. (2022). Immunization policy statement. Pediatrics, 150(1), e2022058465.
  • Trimble, C., & Rose, N. (2021). Vaccination in special populations. Clinical Pediatrics, 60(2), 107-114.
  • Schwarz, C., et al. (2018). Combining vaccines: Efficacy and safety. Vaccine, 36(33), 4918-4924.
  • Stephens, J. E., & Hollingsworth, J. (2020). Pediatric vaccine interventions: Best practices and safety considerations. Vaccine & Immunization Journal, 6(2), 115-122.

Related Assignments